Cargando…
SapC-DOPS nanovesicles: a novel targeted agent for the imaging and treatment of glioblastoma
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. Classified by the World Health Organization (WHO) as grade IV astrocytoma, GBMs are extremely aggressive, almost always recur, and despite our best efforts, remain incurable. This review describes the traditional treatme...
Autores principales: | Blanco, Víctor M., Curry, Richard, Qi, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381703/ https://www.ncbi.nlm.nih.gov/pubmed/25859553 |
Ejemplares similares
-
Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
por: Chu, Zhengtao, et al.
Publicado: (2013) -
Detection of cancer cells using SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2016) -
SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
por: N’Guessan, Kombo F., et al.
Publicado: (2020) -
Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
por: Blanco, Víctor M., et al.
Publicado: (2014) -
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020)